Intramuscular injection of an IGF-1-expressing adeno-associated virus (AAV) delays disease progression and prolongs the lifespan of a transgenic mouse model of ALS expressing the G93A SOD1 transgene [220]. The gene discussed is IGF1; the disease is amyotrophic lateral sclerosis.